FDA Warning Letter — Beijing Taiyang Pharmaceutical Industry Company Ltd
The FDA took a Warning Letter action against Beijing Taiyang Pharmaceutical Industry Company Ltd on October 19, 2016 (Beijing, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Beijing Taiyang Pharmaceutical Industry Company Ltd
- Date
- October 19, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Beijing (China)